和黄医药(HCM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HCM 和黄医药

交易中 04-22 11:49:29 EDT

15.54

+1.65

+11.88%

最高15.85	最低15.08	成交量8.63万
今开15.12	昨收13.89	日振幅5.54%
总市值26.57亿	流通市值15.89亿	总股本1.71亿
成交额132.99万	换手率0.08%	流通股本1.02亿
市净率3.50	ROE5.04%	每股收益0.20
52周最高21.92	52周最低11.51	市盈率77.70
股息0.00	股息收益率0.00	ROA-2.14%

北京优虎网络科技有限公司

{"stockData":{"symbol":"HCM","market":"US","secType":"STK","nameCN":"和黄医药","latestPrice":15.54,"timestamp":1745336834389,"preClose":13.89,"halted":0,"volume":86250,"delay":0,"floatShares":102260992,"shares":170976727,"eps":0.199995,"marketStatus":"交易中","change":1.65,"latestTime":"04-22 11:49:27 EDT","open":15.12,"high":15.85,"low":15.08,"amount":1329939.81,"amplitude":0.055436,"askPrice":15.63,"askSize":227,"bidPrice":15.5,"bidSize":21,"shortable":3,"etf":0,"ttmEps":0.199995,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":1,"adrRate":5,"listingDate":1458187200000,"exchange":"NASDAQ","adjPreClose":13.89,"preHourTrading":{"tag":"盘前","latestPrice":15.0295,"preClose":13.89,"latestTime":"09:21 EDT","volume":9,"amount":135.2655,"timestamp":1745328066410},"postHourTrading":{"tag":"盘后","latestPrice":13.89,"preClose":13.89,"latestTime":"16:05 EDT","volume":322,"amount":4472.58,"timestamp":1745265913534},"volumeRatio":3.458714,"impliedVol":0.7451,"impliedVolPercentile":0.792},"requestUrl":"/m/hq/s/HCM","defaultTab":"news","newsList":[{"id":"2529582025","title":"和黄医药盘中异动 大幅上涨8.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529582025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529582025?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:31","pubTimestamp":1745328698,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时31分，和黄医药股票出现异动，股价快速拉升8.86%。和黄医药股票所在的制药行业中，整体涨幅为0.41%。其相关个股中，Gelteq Limited、苏轩堂、Bausch Health Companies Inc.涨幅较大，Gelteq Limited、苏轩堂、大自然药业较为活跃，换手率分别为497.51%、8.54%、4.48%，振幅较大的相关个股有Gelteq Limited、Scilex Holding Company、大自然药业，振幅分别为53.33%、6.38%、5.07%。该公司目前在全球范围内拥有多个临床研究的癌症候选药物组合，并在其中国本土市场拥有广泛的商业基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213138a6c3da43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213138a6c3da43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","BK4585","HCM","BK4531"],"gpt_icon":0},{"id":"2529362849","title":"和黄医药4月21日成交额为38.48万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529362849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529362849?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:37","pubTimestamp":1745285834,"startTime":"0","endTime":"0","summary":"美东时间2025年4月21日，和黄医药成交额为38.48万美元，成交额较昨日减少18.38%，当日成交量为2.80万股。和黄医药于2025年4月21日涨0.94%，报13.89美元，该股过去5个交易日涨1.24%，年初至今跌3.61%，过去60日涨2.13%。该公司目前在全球范围内拥有多个临床研究的癌症候选药物组合，并在其中国本土市场拥有广泛的商业基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093716a461c24e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093716a461c24e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4531","BK4007","HCM","BK4585","BK4588"],"gpt_icon":0},{"id":"2529366553","title":"【和黄医药(00013.HK)：赛沃替尼用于治疗MET扩增胃癌患者的II期研究的注册阶段已完成患者入组】智通财经APP讯，和黄医药(00013.HK)发布公告，赛沃替尼用于治疗MET扩增胃癌患者的II期研究的注册阶段已完成患者入组。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529366553","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529366553?lang=zh_cn&edition=full","pubTime":"2025-04-22 08:36","pubTimestamp":1745282198,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和黄医药(00013.HK)发布公告，赛沃替尼用于治疗MET扩增胃癌患者的II期研究的注册阶段已完成患者入组。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22083649734607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1989772840.SGD","BK1588","BK1191","BK4531","00013","LU1291159041.SGD","BK4007","BK4162","LU1496350502.SGD","LU1989772923.USD","BK4585","BK1587","LU1989771016.USD","BK4588","MET","HCM"],"gpt_icon":0},{"id":"2529365635","title":"和黄医药(00013)：赛沃替尼用于治疗MET扩增胃癌患者的II期研究的注册阶段已完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2529365635","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529365635?lang=zh_cn&edition=full","pubTime":"2025-04-22 08:28","pubTimestamp":1745281717,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和黄医药 发布公告，赛沃替尼用于治疗MET扩增胃癌患者的II期研究的注册阶段已完成患者入组。如果研究取得积极结果，和黄医药有望于2025年年底在中国启动向国家药监局递交赛沃替尼用于治疗胃癌的上市许可申请。中国每年约新增18000例MET扩增的胃癌病例。目前正在进行中的注册研究是继多项赛沃替尼在亚洲治疗MET驱动的胃癌的II期研究后开展的，其中包括VIKTORY研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","BK4531","LU1291159041.SGD","LU1989771016.USD","LU1989772923.USD","BK4588","BK1587","MET","HCM","BK1191","BK4162","BK4585","BK4007","00013","LU1496350502.SGD","LU1989772840.SGD"],"gpt_icon":0},{"id":"2528782333","title":"和黄医药4月16日成交额为71.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528782333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528782333?lang=zh_cn&edition=full","pubTime":"2025-04-17 09:35","pubTimestamp":1744853750,"startTime":"0","endTime":"0","summary":"美东时间2025年4月16日，和黄医药成交额为71.01万美元，成交额较昨日减少49.79%，当日成交量为5.18万股。和黄医药于2025年4月16日跌4.45%，报13.74美元，该股过去5个交易日涨7.51%，年初至今跌4.65%，过去60日跌3.31%。该公司目前在全球范围内拥有多个临床研究的癌症候选药物组合，并在其中国本土市场拥有广泛的商业基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417093557a6bd400d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417093557a6bd400d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4531","HCM","BK4585","BK4588"],"gpt_icon":0},{"id":"2527156404","title":"和黄医药4月15日成交额为141.42万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527156404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527156404?lang=zh_cn&edition=full","pubTime":"2025-04-16 09:34","pubTimestamp":1744767256,"startTime":"0","endTime":"0","summary":"美东时间2025年4月15日，和黄医药成交额为141.42万美元，成交额较昨日减少29.34%，当日成交量为9.80万股。和黄医药于2025年4月15日跌3.43%，报14.38美元，该股过去5个交易日涨21.76%，年初至今跌0.21%，过去60日涨1.27%。该公司目前在全球范围内拥有多个临床研究的癌症候选药物组合，并在其中国本土市场拥有广泛的商业基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416093427a6bbe5fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416093427a6bbe5fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4531","HCM","BK4585","BK4588","BK4007"],"gpt_icon":0},{"id":"2527108512","title":"和黄医药4月14日成交额为200.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527108512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527108512?lang=zh_cn&edition=full","pubTime":"2025-04-15 09:32","pubTimestamp":1744680767,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，和黄医药成交额为200.12万美元，成交额较昨日减少23.52%，当日成交量为13.54万股。和黄医药于2025年4月14日涨8.53%，报14.89美元，该股过去5个交易日涨22.65%，年初至今涨3.33%，过去60日涨11.79%。该公司目前在全球范围内拥有多个临床研究的癌症候选药物组合，并在其中国本土市场拥有广泛的商业基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415093409a6baa8c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415093409a6baa8c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4531","HCM","BK4585","BK4007","BK4588"],"gpt_icon":0},{"id":"2527316441","title":"和黄医药盘中异动 急速上涨5.03%报14.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527316441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527316441?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:31","pubTimestamp":1744637466,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时31分，和黄医药股票出现异动，股价大幅拉升5.03%。截至发稿，该股报14.41美元/股，成交量2215股，换手率0.00%，振幅0.00%。和黄医药股票所在的制药行业中，整体涨幅为1.39%。该公司目前在全球范围内拥有多个临床研究的癌症候选药物组合，并在其中国本土市场拥有广泛的商业基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213107a6ba1bc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213107a6ba1bc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4007","BK4531","BK4588","HCM"],"gpt_icon":0},{"id":"2526437766","title":"和黄医药(US ADR)上涨10.22%，报13.81美元/股，总市值24.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526437766","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526437766?lang=zh_cn&edition=full","pubTime":"2025-04-12 03:40","pubTimestamp":1744400427,"startTime":"0","endTime":"0","summary":"4月12日，和黄医药盘中上涨10.22%，截至03:40，报13.81美元/股，成交209.2万美元，总市值24.07亿美元。财务数据显示，截至2024年12月31日，和黄医药收入总额6.3亿美元，同比减少24.8%；归母净利润3772.9万美元，同比减少62.56%。大事提醒：4月7日，和黄医药2024年四季度累计回购金额3606万美元。公司还在中国市场建立了深入的具盈利的商业平台,在中国生产、营销及经销自主研发的创新肿瘤药物,以及处方药和消费保健产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041203450994d33084&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041203450994d33084&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4531","BK4585","HCM","BK4007","BK4588"],"gpt_icon":0},{"id":"2518222844","title":"和黄医药盘中异动 早盘股价大跌5.08%报15.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222844?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613471,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，和黄医药股票出现异动，股价快速下挫5.08%。截至发稿，该股报15.69美元/股，成交量3928股，换手率0.00%，振幅0.00%。和黄医药股票所在的制药行业中，整体跌幅为1.05%。其相关个股中，Sonoma Pharmaceuticals, Inc.、苏轩堂、Incannex Healthcare Inc.涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为49.09%、6.91%、2.85%，振幅较大的相关个股有惠普森医药、大自然药业、阿尼卡疗法，振幅分别为12.67%、3.36%、2.68%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213111abf2fbaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213111abf2fbaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCM","BK4007","BK4585","BK4531","BK4588"],"gpt_icon":0},{"id":"2517374324","title":"美股异动 | 和黄医药(HCM.US)涨近4% 完成HMPL-453(fanregratinib)中国II期注册研究患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2517374324","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517374324?lang=zh_cn&edition=full","pubTime":"2025-03-07 23:55","pubTimestamp":1741362908,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，和黄医药涨近4%，报16.64美元。消息面上，3月6日，和黄医药公告，HMPL-453 用于治疗伴有成纤维细胞生长因子受体2融合/重排的肝内胆管癌患者的II期临床试验已完成患者入组。该研究是一项单臂、多中心、开放标签的II期注册研究，旨在评估HMPL-453用于治疗伴有FGFR2融合/重排的晚期肝内胆管癌患者的疗效、安全性和药代动力学。注册研究阶段共纳入87名患者 。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","BK1191","BK4531","00013","BK4007","BK4585","BK1587","BK4588","HCM"],"gpt_icon":0},{"id":"2517142688","title":"和黄医药宣布完成HMPL-453用于治疗肝内胆管癌的中国II期注册研究的患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2517142688","media":"和黄医药官微","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517142688?lang=zh_cn&edition=full","pubTime":"2025-03-07 07:32","pubTimestamp":1741303930,"startTime":"0","endTime":"0","summary":"中国香港、上海和美国新泽西州：2025年3月6日，星期四：和黄医药(中国)有限公司  今日宣布HMPL-453 用于治疗伴有成纤维细胞生长因子受体  2融合/重排的肝内胆管癌患者的II期临床试验已完成患者入组。注册研究阶段共纳入87名患者。和黄医药目前拥有HMPL-453在全球范围内的所有权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307102415a2634a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307102415a2634a15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCM","BK4585","BK4531","BK4007","BK4588"],"gpt_icon":0},{"id":"2517198793","title":"和黄医药盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517198793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517198793?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:01","pubTimestamp":1741280504,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时01分，和黄医药股票出现异动，股价快速下挫5.05%。截至发稿，该股报15.90美元/股，成交量5.3086万股，换手率0.03%，振幅1.65%。和黄医药股票所在的制药行业中，整体跌幅为1.02%。其相关个股中，博美集团、惠普森医药、苏轩堂涨幅较大，Petros Pharmaceuticals, Inc.、德纳维制药、苏轩堂较为活跃，换手率分别为13.48%、8.22%、7.91%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Medicus Pharma Ltd.，振幅分别为33.03%、26.67%、21.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307010144abeb9bdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307010144abeb9bdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","HCM","BK4531","BK4007","BK4588"],"gpt_icon":0},{"id":"2517327331","title":"和黄医药(00013)：完成HMPL-453 (fanregratinib) 用于治疗肝内胆管癌的中国II期注册研究的患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2517327331","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517327331?lang=zh_cn&edition=full","pubTime":"2025-03-06 18:08","pubTimestamp":1741255724,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和黄医药 发布公告，HMPL-453 用于治疗伴有成纤维细胞生长因子受体2融合/重排的肝内胆管癌患者的II期临床试验已完成患者入组。该研究是一项单臂、多中心、开放标签的II期注册研究，旨在评估HMPL-453用于治疗伴有FGFR2融合/重排的晚期肝内胆管癌患者的疗效、安全性和药代动力学。注册研究阶段共纳入87名患者 。HMPL-453 是一种新型、高选择性且强效的FGFR 1 、2和3抑制剂。和黄医药目前拥有HMPL-453在全球范围内的所有权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4531","HCM","BK1191","BK1588","BK4585","BK1587","00013","BK4007","BK4588"],"gpt_icon":0},{"id":"2517944739","title":"和黄医药任命黄德伟为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2517944739","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517944739?lang=zh_cn&edition=full","pubTime":"2025-03-05 18:10","pubTimestamp":1741169423,"startTime":"0","endTime":"0","summary":"3月5日，和黄医药发布公告，宣布黄德伟被委任为公司独立非执行董事及审计委员会成员，自2025年3月6日起生效。根据他的聘任书，黄德伟作为独立非执行董事及审计委员会成员的薪酬分别为每年7.6万美元和1.35万美元，薪酬将依据董事职务与责任及市场情况进行调整，并按比例计算不足一年之任期的薪酬。此外，黄德伟确认与公司董事、高层管理人员及主要股东无任何关系，并满足香港上市规则的独立性要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305181114963a8f46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305181114963a8f46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00013","BK1587","BK1588","HCM"],"gpt_icon":0},{"id":"2517994382","title":"和黄医药(00013)：黄德伟获任独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2517994382","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517994382?lang=zh_cn&edition=full","pubTime":"2025-03-05 18:04","pubTimestamp":1741169076,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和黄医药(00013)发布公告，黄德伟先生获委任为公司独立非执行董事及审核委员会成员，自2025年3月6日起生效。和黄医药主席艾乐德博士表示：“本人谨代表董事会热烈欢迎黄先生加入公司。我们相信，他在财务及会计的丰富经验将为公司的策略增长及财务管理作出重大贡献。”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258088.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00013","BK1588","BK4531","BK1587","BK1191","BK4585","HCM","BK4588","BK4007"],"gpt_icon":0},{"id":"2516688675","title":"上海医药拟收购和黄医药10%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2516688675","media":"经济观察报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516688675?lang=zh_cn&edition=full","pubTime":"2025-03-03 16:50","pubTimestamp":1740991800,"startTime":"0","endTime":"0","summary":"公司动态　　经济观察网讯 3月2日，上海医药（601607.SH）发布公告，拟以约9.95亿元（以最终国资备案价格为准）收购和黄药业10%股权。目前上海医药已持有和黄药业50%股权，此次交易完成后，其持有持股将达60%，并实现并表。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2025-03-03/doc-inenkmne9161691.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-03-03/doc-inenkmne9161691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4531","BK4585","BK4007","BK0099","HCM","00013","BK0175","BK1587","BK1197","BK0196","BK0028","BK0097","BK4588","BK1588","BK0184","BK0209","BK0020","BK1191","BK0183","BK0012","02607","BK0187","BK0188","601607"],"gpt_icon":0},{"id":"2516351987","title":"和黄医药(00013)金浦健服股权投资管理指定上海金浦志诚私募投资基金合伙企业及上海金浦志佰合企业管理合伙企业作为买方","url":"https://stock-news.laohu8.com/highlight/detail?id=2516351987","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516351987?lang=zh_cn&edition=full","pubTime":"2025-03-02 19:07","pubTimestamp":1740913649,"startTime":"0","endTime":"0","summary":"鉴于公司于过去二十年已在中国建立起强大的业务基础，公司会将建议出售事项所得款项再次投资于其在中国经营的业务。是次出售将促进资源分配，使这些资源可以重新调配至公司在中国开展的创新性举措，特别是旨在强化其研发能力以及扩大其生产及商业化基础设施的举措。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HCM","BK4588","BK4007","BK1588","159830","BK4531","00013","BK1587","BK4585","BK1191"],"gpt_icon":0},{"id":"2514856938","title":"和黄医药盘中异动 早盘股价大涨6.35%报16.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856938?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580264,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，和黄医药股票出现波动，股价快速拉升6.35%。截至发稿，该股报16.74美元/股，成交量1955股，换手率0.00%，振幅0.00%。和黄医药股票所在的制药行业中，整体跌幅为0.13%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Sunshine Biopharma Inc C/Wts 、和黄医药涨幅较大，苏轩堂、Quantum Biopharma Ltd.、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为5.91%、3.27%、2.51%，振幅较大的相关个股有大自然药业、Quantum Biopharma Ltd.、Avadel Pharmaceuticals Plc，振幅分别为3.13%、3.05%、1.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223104a254f608&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223104a254f608&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCM","BK4585","BK4531","BK4007","BK4588"],"gpt_icon":0},{"id":"2513772274","title":"和黄医药盘中异动 急速跳水5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513772274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513772274?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:34","pubTimestamp":1740407651,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时34分，和黄医药股票出现异动，股价大幅下跌5.34%。截至发稿，该股报15.25美元/股，成交量6709股，换手率0.00%，振幅3.04%。机构评级方面，在所有18家参与评级的机构中，94%的券商给予买入建议，6%的券商给予持有建议，无券商给予卖出建议。和黄医药股票所在的制药行业中，整体涨幅为0.36%。该公司经营两个可报告的肿瘤学/免疫学部门和其他风险投资部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223411a2521506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223411a2521506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","HCM","BK4588","BK4531","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hutch-med.com","stockEarnings":[{"period":"1week","weight":-0.0672},{"period":"1month","weight":-0.0734},{"period":"3month","weight":-0.0225},{"period":"6month","weight":-0.3494},{"period":"1year","weight":-0.1582},{"period":"ytd","weight":-0.0361}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"和黄医药（中国）有限公司是一间主要从事制造及销售药物的投资控股公司。该公司主要通过两个分部运营业务。肿瘤免疫业务分部从事发现、开发和商业化用于治疗癌症和免疫性疾病的靶向疗法和免疫疗法。其中研发包括涵盖药物发现、开发、生产及监管职能的研发活动，上市产品包括通过研发活动开发的药物的已开具发票的销售、推广、生产及分销。其他业务分部从事其他商业化业务，包括其他处方药物及保健品的销售、推广、生产及分销。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.048009},{"month":2,"riseRate":0.444444,"avgChangeRate":0.016796},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.014296},{"month":4,"riseRate":0.5,"avgChangeRate":0.030477},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.070144},{"month":6,"riseRate":0.666667,"avgChangeRate":0.076759},{"month":7,"riseRate":0.555556,"avgChangeRate":0.038822},{"month":8,"riseRate":0.444444,"avgChangeRate":0.020061},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.025072},{"month":10,"riseRate":0.555556,"avgChangeRate":-0.0009},{"month":11,"riseRate":0.777778,"avgChangeRate":0.124286},{"month":12,"riseRate":0.555556,"avgChangeRate":-0.010371}],"exchange":"NASDAQ","name":"和黄医药","nameEN":"Hutchison China Meditech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和黄医药(HCM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和黄医药(HCM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和黄医药,HCM,和黄医药股票,和黄医药股票老虎,和黄医药股票老虎国际,和黄医药行情,和黄医药股票行情,和黄医药股价,和黄医药股市,和黄医药股票价格,和黄医药股票交易,和黄医药股票购买,和黄医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和黄医药(HCM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和黄医药(HCM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}